ID

Ian Dixon

Entropy Neurodynamics Limited | Chief Executive Officer
Dr Dixon co-founded Cynata Inc in 2011, now a subsidiary of ASX-listed Cynata Therapeutics Ltd, a stem cell and regenerative medicine company. In 2014, Ian co-founded Cardio Therapeutics Pty Ltd and managed the PCSK9 cardiovascular discovery program until the company was acquired by Nyrada Inc in advance of the IPO of Nyrada in 2019. In 2018, the genetic medicines company founded by Ian listed on the ASX as Exopharm Ltd, now Entropy Neurodynamics Limited Ian was also a co-inventor of several inventions in the exosome field, including a number of granted U.S. patents.

Companies and Roles

Company
Title
Tenure
Since
ENP
ENP
Entropy Neurodynamics Limited
  • Chief Executive Officer
13yrs, 3mthMay 2013
NYR
NYR
Nyrada Inc
  • Founder
  • Non-Executive Director
5yrs, 11mthSep 2020

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
NYR
NYR
Nyrada Inc
30/06/26N/A9,780,6991,800,000N/A
ENP
ENP
Entropy Neurodynamics Limited
01/05/24N/A11,303,451N/AN/A
TYP
TYP
01/05/24N/A11,303,451N/AN/A
EX1
EX1
19/04/24N/A11,303,451N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
NYR
NYR
Nyrada Inc
20/02/26
Issued
1,200,000$0.580$696,000Issue of options
NYR
NYR
Nyrada Inc
18/12/25
Sell
600,000$0.646$387,600Off-market trade
NYR
NYR
Nyrada Inc
12/06/24
Issued
266,666$0.075$19,999Placement
EX1
EX1
01/09/21
Buy
83,333$0.535$44,583Conversion of securities
EX1
EX1
01/09/21
Exercise
83,333$0.535$44,583Conversion of securities